Výsledky vyhledávání - Shin‐Cheh Chen

  • Zobrazuji výsledky 1 - 19 z 19
Upřesnit hledání
  1. 1
    Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells

    Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells Autor Hsien Liu, Shih-Han Wang, Shin‐Cheh Chen, Ching-Ying Chen, Tsun‐Mei Lin

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    Differential microRNA expression in breast cancer with different onset age

    Differential microRNA expression in breast cancer with different onset age Autor Hsiu-Pei Tsai, Shiang‐Fu Huang, Chien-Fan Li, Huei‐Tzu Chien, Shin‐Cheh Chen

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions

    Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions Autor Shin‐Cheh Chen, Horng-Ren Yang, Tsann‐Long Hwang, Miin‐Fu Chen, Yun‐Chung Cheung, Swei Hsueh

    Vydáno 2003
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    A reappraisal of cholangiocarcinoma in patient with hepatolithiasis

    A reappraisal of cholangiocarcinoma in patient with hepatolithiasis Autor Miin-Fu Chen, Yi-Yin Jan, Chia‐Siu Wang, Tsann‐Long Hwang, Long-Bing Jeng, Shin‐Cheh Chen, Tong‐Jong Chen

    Vydáno 1993
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties

    Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties Autor Ying-Jhen Su, Wei‐Hsin Lin, Yi‐Wen Chang, Kuo‐Chen Wei, Chi-Lung Liang, Shin‐Cheh Chen, Jia-Lin Lee

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women

    Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women Autor Yun‐Chung Cheung, Yu‐Hsiang Juan, Yu‐Ching Lin, Yung‐Feng Lo, Hsiu-Pei Tsai, Shir‐Hwa Ueng, Shin‐Cheh Chen

    Vydáno 2016
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Diverse Targets of β-Catenin during the Epithelial–Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse

    Diverse Targets of β-Catenin during the Epithelial–Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse Autor Yi‐Wen Chang, Ying-Jhen Su, Michael Hsiao, Kuo‐Chen Wei, Wei‐Hsin Lin, Chi-Jung Liang, Shin‐Cheh Chen, Jia-Lin Lee

    Vydáno 2015
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Quantitative analysis of enhanced malignant and benign lesions on contrast-enhanced spectral mammography

    Quantitative analysis of enhanced malignant and benign lesions on contrast-enhanced spectral mammography Autor Chih-Ying Deng, Yu‐Hsiang Juan, Yun‐Chung Cheung, Yu‐Ching Lin, Yung‐Feng Lo, Gigin Lin, Shin‐Cheh Chen, Shu‐Hang Ng

    Vydáno 2018
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer

    Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer Autor Christian Jackisch, Daniil Stroyakovskiy, Xavier Pivot, Jin Seok Ahn, Bohuslav Melichar, Shin‐Cheh Chen, Christoph Meyenberg, N. Al-Sakaff, Dominik Heinzmann, Roberto Hegg

    Vydáno 2019
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer

    nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HE... Autor Erika Hamilton, Javier Cortés, Özgür Özyılkan, Shin‐Cheh Chen, Katarína Petráková, Alexey Manikhas, Guy Jérusalem, Roberto Hegg, Jens Huober, Wei Zhang, Yanyun Chen, Miguel Martín

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer

    WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer Autor Kun‐Chun Chiang, Chun‐Nan Yeh, Li‐Chuan Chung, Tsui‐Hsia Feng, Chi-Chin Sun, Miin‐Fu Chen, Yi-Yin Jan, Ta‐Sen Yeh, Shin‐Cheh Chen, Horng‐Heng Juang

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan

    Increased Risk for Second Primary Malignancies in Women with Breast Cancer Diagnosed at Young Age: A Population-Based Study in Taiwan Autor Kuan‐Der Lee, Shin‐Cheh Chen, Chunghuang Hubert Chan, Chang-Hsien Lu, Chih‐Cheng Chen, Jen-Tsun Lin, Miao-Fen Chen, Shih‐Hao Huang, Chun-Ming Yeh, Min-Chi Chen

    Vydáno 2008
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up

    HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuva... Autor Christian Jackisch, Roberto Hegg, Daniil Stroyakovskiy, Jin‐Seok Ahn, Bohuslav Melichar, Shin‐Cheh Chen, Sung‐Bae Kim, Mikhail Lichinitser, Elżbieta Starosławska, G. Kunz, S. Falcon, Shou‐Tung Chen, A. Crepelle-Fléchais, Dominik Heinzmann, Mona Shing, Xavier Pivot

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy

    Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy Autor Hsu‐Huan Chou, Wen‐Ling Kuo, Chi‐Chang Yu, Hsiu-Pei Tsai, Shih-Cheh Shen, Chia‐Hui Chu, Ming‐Chin Yu, Yung‐Feng Lo, Muawiya A. Dabora, Hsien‐Kun Chang, Yung‐Chang Lin, Shir‐Hwa Ueng, Shin‐Cheh Chen

    Vydáno 2019
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer

    Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer Autor Masato Takahashi, Javier Cortés, Rebecca Dent, Lajos Pusztai, Heather L. McArthur, Sherko Kümmel, Carsten Denkert, Winnie Yeo, Seock‐Ah Im, Jin‐Hee Ahn, Hirofumi Mukai, Chiun‐Sheng Huang, Shin‐Cheh Chen, Min Hwan Kim, Liyi Jia, Xin Tong Li, Konstantinos Tryfonidis, Vassiliki Karantza, Hiroji Iwata, Peter Schmid

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

    Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study Autor Chiun‐Sheng Huang, Alice L. Yu, Ling‐Ming Tseng, Louis W.C. Chow, Ming‐Feng Hou, Sara A. Hurvitz, Richard B. Schwab, James L. Murray, Hsien‐Kun Chang, Hong‐Tai Chang, Shin‐Cheh Chen, Sung‐Bae Kim, Jung‐Tung Hung, Shir‐Hwa Ueng, Su-Hua Lee, Chwen-Cheng Chen, Hope S. Rugo

    Vydáno 2020
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant Trial

    Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant... Autor Aditya Bardia, Marina Parton, Sherko Kümmel, Laura García‐Estévez, Chiun‐Sheng Huang, Javier Cortés, Manuel Ruíz‐Borrego, Melinda L. Telli, Paloma Martín-Martorell, Rafael López‐López, J. Thaddeus Beck, Roohi Ismail‐Khan, Shin‐Cheh Chen, Sara A. Hurvitz, Ingrid A. Mayer, D. Carreon, Scott B. Cameron, Serena G. Liao, José Baselga, Sung‐Bae Kim

    Vydáno 2018
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, plac... Autor Sung‐Bae Kim, Rebecca Dent, Seock‐Ah Im, Marc Espié, Sibel Blau, Antoinette R. Tan, Steven J. Isakoff, Mafalda Oliveira, Cristina Saura, Matthew Wongchenko, Amy V. Kapp, Wai Yee Chan, Stina Mui Singel, Daniel Maslyar, José Baselga, Sungbae Kim, Keun Seok Lee, Seock‐Ah Im, Marc Espié, Hwei-Chung Wang, Sibel Blau, Rebecca Dent, Antoinette R. Tan, Joohyuk Sohn, Michelino De Laurentiis, Laura García‐Estévez, Chiun‐Sheng Huang, Gilles Romieu, Michel Velez, Rafael Villanueva-Vázquez, Pierfranco Conté, Shaker R. Dakhil, Marc Debled, Antonio González-Martı́n, Sara A. Hurvitz, Jee Hyun Kim, Christelle Lévy, Mafalda Oliveira, Pedro Sánchez‐Rovira, Jae Hong Seo, Vicente Valero, Gregory A. Vidal, Andrea Wong, Mary Ann Allison, Robert A. Figlin, David Chan, Shin‐Cheh Chen, Yen‐Hsun Chen, Melody A. Cobleigh, Filippo de Braud, Luc Dirix, Vincent Hansen, Anne Hardy Bessard, Nicholas Iannotti, Steven J. Isakoff, William Lawler, Álvaro Montaño, Mohamad Salkini, L. Seigel

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer

    Final results of RIGHT Choice: Ribociclib plus endocrine therapy vs combination chemotherapy in premenopausal women with clinically aggressive HR+/HER2− advanced breast cancer Autor Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim, Yeşim Eralp, Yoon Sim Yap, Seock‐Ah Im, Julie Rihani, Erhan Gökmen, Ahmed El Bastawisy, Nuri Karadurmuş, Yueh Ni Lim, Chun Sen Lim, Le Thanh Duc, Wei‐Pang Chung, Govind Babu, Konstantin Penkov, James Bowles, T. Delgar Alfaro, Jiwen Wu, Melissa Gao, Khémaies Slimane, Nagi S. El Saghir, Adher Alsayed, Ahmed El Bastawisy, Ajay Gogia, Chaiyut Charoentum, Chanchal Goswami, Chien-Ting Liu, Chun Sen Lim, Е. В. Артамонова, Erhan Gökmen, Esat Namal, Eznal Izwadi Mohd Mahidin, Fadi Farhat, Flora Chong Li Tze, Gül Başaran, Hakan Harputluoğlu, Hamdy A. Azim, Hikmat Abdel‐Razeq, Hesham Ahmed ElGhazaly, K. Govind Babu, Konstantin Penkov, Le Thanh Duc, Ling‐Ming Tseng, Liudmila Osmanova, Lyudmila Zhukova, Meher Lakshmi Konatum, Mehmet Alı Nahıt Şendur, Ming‐Shen Dai, Mona Ayoubi, Nagi S. El Saghir, Naiyarat Prasongsook, Napa Parinyanitikul, Nikita Volkov, Nuri Karadurmuş, Patrapim Sunpaweravong, Peter Ang, Pei Jye Voon, Rabab Gaafar, Rasha Abdel Motagaly, Richard Khanyile, Sema Sezgin Göksu, Shin‐Cheh Chen, Sudeep Gupta, Su Mien Lynette Ngo, Swee Hsia Choong, Terence Aik Huang Tan, Umut Demırcı, Wei‐Pang Chung, Wen‐Son Hsieh, Yen‐Shen Lu, Yeşim Eralp, Yoon Sim Yap, Yuan‐Ching Chang, Yueh Ni Lim

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: